Microbleeds relate to altered amyloid-beta metabolism in Alzheimer's disease

Neurobiology of Aging

Volumn 33, Issue 5, 2012, Pages 1011.e1-1011.e9

  Goos, Jeroen D C ^a,b   Teunissen, Charlotte E ^a,b   Veerhuis, Robert ^a,b   Verwey, Nicolaas A ^a,b   Barkhof, Frederik ^a,b   Blankenstein, Marinus A ^a,b   Scheltens, Philip ^a,b   Van der Flier, Wiesje M ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Cerebral amyloid angiopathy; Cerebrospinal fluid; MRI; Vascular dementia

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42];

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER DYSFUNCTION; BRAIN DISEASE; BRAIN HEMORRHAGE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN METABOLISM; VASCULAR AMYLOIDOSIS;

EID: 84858341147     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.10.026     Document Type: Article

References (41)

1. Alonzo N.C., Hyman B.T., Rebeck G.W., Greenberg S.M. Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels. J. Neuropathol. Exp. Neurol 1998, 57:353-359.
2. Atri A., Locascio J.J., Lin J.M., Yap L., Dickerson B.C., Grodstein F., Irizarry M.C., Growdon J.H., Greenberg S.M. Prevalence and effects of lobar microhemorrhages in early-stage dementia. Neurodegener. Dis 2005, 2:305-312.
3. Attems J. Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms. Acta Neuropathol 2005, 110:345-359.
4. Attems J., Jellinger K.A. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology-a pilot study. Acta Neuropathol 2004, 107:83-90.
5. Attems J., Lintner F., Jellinger K.A. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology. Acta Neuropathol 2004, 107:283-291.
6. Bibl M., Mollenhauer B., Esselmann H., Schneider M., Lewczuk P., Welge V., Gross M., Falkai P., Kornhuber J., Wiltfang J. Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review. Dement. Geriatr. Cogn. Disord 2008, 25:256-265.
7. Blennow K., Hampel H. CSF markers for incipient Alzheimer's disease. Lancet Neurol 2003, 2:605-613.
8. Bouwman F.H., Schoonenboom S.N., van der Flier W.M., van Elk E.J., Kok A., Barkhof F., Blankenstein M.A., Scheltens P. CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment. Neurobiol. Aging 2007, 28:1070-1074.
9. Cordonnier C., van der Flier W.M., Sluimer J.D., Leys D., Barkhof F., Scheltens P. Prevalence and severity of microbleeds in a memory clinic setting. Neurology 2006, 66:1356-1360.
10. Dierksen G.A., Skehan M.E., Khan M.A., Jeng J., Nandigam R.N., Becker J.A., Kumar A., Neal K.L., Betensky R.A., Frosch M.P., Rosand J., Johnson K.A., Viswanathan A., Salat D.H., Greenberg S.M. Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann. Neurol 2010, 68:545-548.
11. Farrall A.J., Wardlaw J.M. Blood-brain barrier: ageing and microvascular disease-systematic review and meta-analysis. Neurobiol. Aging 2009, 30:337-352.
12. Fazekas F., Chawluk J.B., Alavi A., Hurtig H.I., Zimmerman R.A. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am. J. Roentgenol 1987, 149:351-356.
13. Fazekas F., Kleinert R., Roob G., Kleinert G., Kapeller P., Schmidt R., Hartung H.P. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am. J. Neuroradiol 1999, 20:637-642.
14. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res 1975, 12:189-198.
15. Gomis M., Sobrino T., Ois A., Millán M., Rodríguez-Campello A., Pérez de la Ossa N., Rodríguez-González R., Jiménez-Conde J., Cuadrado-Godia E., Roquer J., Dávalos A. Plasma beta-amyloid 1-40 is associated with the diffuse small vessel disease subtype. Stroke 2009, 40:3197-3201.
16. Goos J.D., Kester M.I., Barkhof F., Klein M., Blankenstein M.A., Scheltens P., van der Flier W.M. Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition. Stroke 2009, 40:3455-3460.
17. Greenberg S.M., Grabowski T., Gurol M.E., Skehan M.E., Nandigam R.N., Becker J.A., Garcia-Alloza M., Prada C., Frosch M.P., Rosand J., Viswanathan A., Smith E.E., Johnson K.A. Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B. Ann. Neurol 2008, 64:587-591.
18. Greenberg S.M., Nandigam R.N., Delgado P., Betensky R.A., Rosand J., Viswanathan A., Frosch M.P., Smith E.E. Microbleeds versus macrobleeds: evidence for distinct entities. Stroke 2009, 40:2382-2386.
19. Gurol M.E., Irizarry M.C., Smith E.E., Raju S., Diaz-Arrastia R., Bottiglieri T., Rosand J., Growdon J.H., Greenberg S.M. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology 2006, 66:23-29.
20. Hanyu H., Tanaka Y., Shimizu S., Takasaki M., Abe K. Cerebral microbleeds in Alzheimer's disease. J. Neurol 2003, 250:1496-1497.
21. Jensen M., Schröder J., Blomberg M., Engvall B., Pantel J., Ida N., Basun H., Wahlund L.O., Werle E., Jauss M., Beyreuther K., Lannfelt L., Hartmann T. Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression. Ann. Neurol 1999, 45:504-511.
22. Kester M.I., Verwey N.A., van Elk E.J., Scheltens P., Blankenstein M.A. Evaluation of plasma Abeta40 and Abeta42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment. Neurobiol Aging 2010, 31:539-540. author reply, 41.
23. Knudsen K.A., Rosand J., Karluk D., Greenberg S.M. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 2001, 537-539.
24. Le Bastard N., Leurs J., Blomme W., De Deyn P.P., Engelborghs S. Plasma amyloid-beta forms in Alzheimer's disease and non-Alzheimer's disease patients. J. Alzheimers Dis 2010, 21:291-301.
25. Lee S.H., Kim S.M., Kim N., Yoon B.W., Roh J.K. Cortico-subcortical distribution of microbleeds is different between hypertension and cerebral amyloid angiopathy. J. Neurol. Sci 2007, 258:111-114.
26. Maia L.F., Mackenzie I.R., Feldman H.H. Clinical phenotypes of cerebral amyloid angiopathy. J. Neurol. Sci 2007, 257:23-30.
27. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
28. Mehta P.D., Pirttilä T., Mehta S.P., Sersen E.A., Aisen P.S., Wisniewski H.M. Plasma and cerebrospinal fluid levels of amyloid β proteins 1-40 and 1-42 in Alzheimer disease. Arch. Neurol 2000, 57:100-105.
29. Mulder C., Verwey N.A., van der Flier W.M., Bouwman F.H., Kok A., van Elk E.J., Scheltens P., Blankenstein M.A. Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. Clin. Chem 2010, 56:248.
30. Mulder S.D., Hack C.E., van der Flier W.M., Scheltens P., Blankenstein M.A., Veerhuis R. Evaluation of intrathecal serum amyloid P (SAP) and C-reactive protein (CRP) synthesis in Alzheimer's disease with the use of index values. J. Alzheimers Dis 2010, 22:1073-1079.
31. Pasquier F., Leys D., Weerts J.G., Mounier-Vehier F., Barkhof F., Scheltens P. Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur. Neurol 1996, 36:268-272.
32. Pettersen J.A., Sathiyamoorthy G., Gao F.Q., Szilagyi G., Nadkarni N.K., St George-Hyslop P., Rogaeva E., Black S.E. Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. Arch. Neurol 2008, 65:790-795.
33. Román G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H., Amaducci L., Orgogozo J.M., Brun A., Hofman A., et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993, 43:250.
34. Scheltens P., Launer L.J., Barkhof F., Weinstein H.C., van Gool W.A. Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J. Neurol 1995, 242:557-560.
35. Simonsen A.H., Hansson S.F., Ruetschi U., McGuire J., Podust V.N., Davies H.A., Mehta P., Waldemar G., Zetterberg H., Andreasen N., Wallin A., Blennow K. Amyloid beta1-40 quantification in CSF: comparison between chromatographic and immunochemical methods. Dement. Geriatr. Cogn. Disord 2007, 23:246-250.
36. Skoog I., Wallin A., Fredman P., Hesse C., Aevarsson O., Karlsson I., Gottfries C.G., Blennow K. A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia. Neurology 1998, 50:966.
37. Teunissen C.E., Petzold A., Bennett J.L., Berven F.S., Brundin L., Comabella M., Franciotta D., Frederiksen J.L., Fleming J.O., Furlan R., Hintzen R.Q., Hughes S.G., Johnson M.H., Krasulova E., Kuhle J., Magnone M.C., Rajda C., Rejdak K., Schmidt H.K., van Pesch V., Waubant E., Wolf C., Giovannoni G., Hemmer B., Tumani H., Deisenhammer F. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology 2009, 73:1914-1922.
38. van Oijen M., Hofman A., Soares H.D., Koudstaal P.J., Breteler M.M. Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study. Lancet Neurol 2006, 5:655-660.
39. Verbeek M.M., Kremer B.P., Rikkert M.O., Van Domburg P.H., Skehan M.E., Greenberg S.M. Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy. Ann. Neurol 2009, 66:245-249.
40. Verhage F. Intelligence and Age: Study With Dutch People Aged 12-77 [in Dutch]. Van Gorcum, Assen 1964.
41. Verwey N.A., Veerhuis R., Twaalfhoven H.A., Wouters D., Hoozemans J.J., Bollen Y.J., Killestein J., Bibl M., Wiltfang J., Hack C.E., Scheltens P., Blankenstein M.A. Quantification of amyloid-beta 40 in cerebrospinal fluid. J. Immunol. Methods 2009, 348:57-66.